Similar articles

• Regulated expression of a dominant negative form of Rev improves resistance to HIV replication in T cells.

  Liu J, Woffendin C, Yang ZY, Nabel GJ. Liu J, et al. Gene Ther. 1994 Jan;1(1):32-7. Gene Ther. 1994. PMID: 7584057
• Cytokine modulation of HIV expression.

  Poli G, Fauci AS. Poli G, et al. Semin Immunol. 1993 Jun;5(3):165-73. doi: 10.1006/smim.1993.1020. Semin Immunol. 1993. PMID: 7688596 Review.
• Antitat gene therapy: a candidate for late-stage AIDS patients.

  Lisziewicz J, Sun D, Lisziewicz A, Gallo RC. Lisziewicz J, et al. Gene Ther. 1995 May;2(3):218-22. Gene Ther. 1995. PMID: 7614253
• Human immunodeficiency virus (HIV) type 2-mediated inhibition of HIV type 1: a new approach to gene therapy of HIV-infection.

  Arya SK, Gallo RC. Arya SK, et al. Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4486-91. doi: 10.1073/pnas.93.9.4486. Proc Natl Acad Sci U S A. 1996. PMID: 8633095 Free PMC article.
• Molecular biology of human immunodeficiency virus type 1.

  Wang WK, Chen MY, Chuang CY, Jeang KT, Huang LM. Wang WK, et al. J Microbiol Immunol Infect. 2000 Sep;33(3):131-40. J Microbiol Immunol Infect. 2000. PMID: 11045374 Review.